DCP Participation at Biomedical Engineering Society (BMES) Annual Meeting - October 24, 2024

Date Posted

Banner of the BMES 2024 Annual Meeting

The Biomedical Engineering Society (BMES) Annual Meeting will be held October 23-26, 2024, in Baltimore. “Synergizing Research and Cultural Excellence” is this year’s theme.

The NCI Division of Cancer Prevention staff will be presenting on October 24th. View the full online BMES schedule.

NCI Programs to develop and translate technologies to the clinic for cancer prevention

Session Chair: Erin Lavik, Sc.D., Chief Technology Officer and Deputy Director, Division of Cancer Prevention, NCI

Presentation Information

Presentation ID: 2886615
Original Submission ID: 1839815
Presentation Title: NCI Drives Technical Innovation for Cancer Research
Presenter: Kelly Crotty, Ph.D., Program Director, Center for Strategic Scientific Initiatives, NCI

Presentation Date and Time

Date: Thursday October 24, 2024
Start Time: 8:30 AM
End Time: 8:50 AM

Location

Room 347

Presentation Information

Presentation ID: 2886614
Original Submission ID: 1839810
Presentation Title: Colon-targeted Drug Delivery Can Improve the Success Rate of Colon Cancer Prevention
Presenting Author: Vignesh Gunasekharan, Ph.D., Program Officer and Deputy Director of PREVENT Operations, Division of Cancer Prevention, NCI
Co-Author(s): Erin Lavik, Sc.D., Chief Technology Officer and Deputy Director, Division of Cancer Prevention, NCI
Last Author(s): Shizuko Sei, M.D., Co-chief, Medical Officer, Division of Cancer Prevention, NCI

Presentation Date and Time

Date: Thursday October 24, 2024
Start Time: 8:50 AM
End Time: 9:10 AM

Location

Room 347

Presentation Information

Presentation ID: 2886616
Original Submission ID: 1839817
Presentation Title: The NCI PREVENT Drug Development Program for Clinical Translation
Presenting Author: John Clifford, Ph.D., Program Officer, Division of Cancer Prevention, NCI
Co-Author(s): Vignesh Gunasekharan, Ph.D., Program Officer and Deputy Director of PREVENT Operations, Division of Cancer Prevention, NCI
Daniel Boring, R.Ph., Ph.D., Scientific Program Manager, Division of Cancer Prevention, NCI
Brian Cholewa, Ph.D., Contracting Officer Representative, Division of Cancer Prevention, NCI
Mark Miller, Ph.D., Deputy Director of PREVENT, Division of Cancer Prevention, NCI
Ancy Nalli, Ph.D., M.S., Program Officer, Division of Cancer Prevention, NCI
Anda Vlad, M.D., Ph.D., Program Officer, Division of Cancer Prevention, NCI
Last Author: Shizuko Sei, M.D., Co-chief, Program Officer, Division of Cancer Prevention, NCI

Presentation Date and Time

Date: Thursday October 24, 2024
Start Time: 9:10 AM
End Time: 9:30 AM

Location

Room 347

Presentation Information

Presentation ID: 2886617
Original Submission ID: 1839818
Presentation Title: Early Phase Cancer Prevention Trials at the NCI – Opportunities for Collaboration
Presenter: Eva Szabo, M.D., Chief, Program Officer, Division of Cancer Prevention, NCI

Presentation Date and Time Information

Date: Thursday October 24, 2024
Start Time: 9:30 AM
End Time: 9:50 AM

Location

Room 347

Presentation Information

Presentation ID: 2887627
Original Submission ID: 1839817
Presentation Title: Open Session
Moderator: Erin Lavik, Sc.D., Chief Technology Officer and Deputy Director, Division of Cancer Prevention, NCI

Presentation Date and Time

Date: Thursday October 24, 2024
Start Time: 9:50 AM
End Time: 10:00 AM

Location

Room 347